Overseeing anxiety and depression in patients with physical illness

Chest

Volumn 144, Issue 3, 2013, Pages 726-728

  Yohannes, Abebaw M ^a   Lavoie, Kim L ^b,c,d  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ANXIETY; BEHAVIOR DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; HEART FAILURE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PHYSICAL DISABILITY; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY REHABILITATION; RISK ASSESSMENT; SOCIAL ISOLATION; SYMPTOM; TREATMENT RESPONSE;

EID: 84884294371     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0511     Document Type: Editorial

References (12)

1. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007 ; 370 (9590): 851-858.
2. Maurer J, Rebbapragada V, Borson S, et al ; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 ; 134 (suppl 4): 43S-56S.
3. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 ; 25 (12): 1209-1221.
4. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 ; 160 (14): 2101-2107.
5. Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012 ; 68 (10): 1365-1373.
6. Moser DK, McKinley S, Riegel B, et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosom Med. 2011 ; 73 (9): 803-809.
7. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 ; 349 (9064): 1498-1504.
8. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011 ; 21 (9): 655-679.
9. Pajak A, Jankowski P, Kotseva K, Heidrich J, de Smedt D, De Bacquer D ; EUROASPIRE Study Group. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol. 2013; 20(2): 331-340.
10. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013 ; 144 (3): 766-777.
11. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007; 167(1): 60-67.
12. Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012 ; 185 (9): 918-923.